HRH Princess Ghida Talal Signs MoU with Novartis International

HRH Princess Ghida Talal Signs MoU with Novartis International
05.10.2017

Basel, September 2017: HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and Center (KHCC), signed a memorandum of understanding (MoU) with Novartis International to promote cooperation between the two institutions in the field of scientific research.

The MoU was also signed by Mr. Bruno Strigini, Novartis Oncology CEO.

On this occasion, HRH Princess Ghida said: "Research is an integral part of KHCC's mission to improve cancer diagnosis and treatment, in line with the Center's efforts to save the lives of our patients."

Dr. Asem Mansour, KHCC Director General, and Dr. Hikmat Abdul-Razeq, KHCC Deputy Director General, attended the ceremony on behalf of KHCC.